Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease

Background Sickle cell disease (SCD) is an inherited disorder of red blood cell (RBC) caused by a mutation in the beta-globin gene resulting in abnormal hemoglobin known as hemoglobin S (HbS) or the sickle hemoglobin. Several clinical variants of SCD have been elucidated, all driven by two fundament...

Descripción completa

Detalles Bibliográficos
Autores principales: Anusim, Nwabundo, Gupta, Ruby, Ahaneku, Hycienth O, Franklin, Candace, Balaraman, Savitha, Huben, Marianne Terese, Jaiyesimi, Ishmael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
113.Hemoglobinopathies, Excluding Thalassemia-New Genetic Approaches to Sickle Cell Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330372/
http://dx.doi.org/10.1182/blood-2020-138739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330372/
http://dx.doi.org/10.1182/blood-2020-138739

Ejemplares similares